+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aneurysm Coiling & Embolization Devices Market by Product Type, Procedure Type, End User, Sales Channel - Global Forecast to 2030- Product Image
Aneurysm Coiling & Embolization Devices Market by Product Type, Procedure Type, End User, Sales Channel - Global Forecast to 2030- Product Image
Sale

Aneurysm Coiling & Embolization Devices Market by Product Type, Procedure Type, End User, Sales Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337108
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Aneurysm Coiling & Embolization Devices Market grew from USD 322.08 million in 2024 to USD 356.40 million in 2025. It is expected to continue growing at a CAGR of 10.46%, reaching USD 585.26 million by 2030.

Unveiling the Evolving Aneurysm Treatment Landscape

Aneurysm coiling and embolization devices represent a critical frontier in neurovascular treatment, offering minimally invasive solutions to a life-threatening condition. As intracranial aneurysms continue to pose significant clinical challenges, the evolution of device technology and procedural protocols has reshaped therapeutic paradigms. Innovations such as advanced hydrogel coatings, next-generation flow diverters, and biocompatible liquid embolics have expanded the armamentarium available to physicians, improving procedural efficacy and patient outcomes.

This introduction traverses the technological milestones and clinical achievements that have elevated aneurysm coiling from a niche intervention to a standard of care in many healthcare systems. It underscores the interplay between device performance, safety profiles, and regulatory approvals, highlighting the accelerated pace of innovation driven by both academic research and industry collaboration. By setting the stage with the current state of play, this section prepares stakeholders to appreciate the transformative shifts that will be examined in the ensuing analysis.

Pivotal Transformations Shaping Device Adoption

Over the past decade, the aneurysm coiling and embolization market has undergone transformative shifts that have redefined competitive dynamics and market priorities. Key advancements in mesh design and polymer science have yielded flow diverters capable of redirecting blood flow with unprecedented precision, disrupting the traditional reliance on platinum coils. Meanwhile, bioactive coatings and hydrogel technologies have enhanced aneurysm occlusion rates and reduced recanalization risks, prompting clinicians to reassess device selection criteria.

Parallel to technological innovation, regulatory pathways have become more streamlined, enabling faster market access for breakthrough therapies. Strategic partnerships between device manufacturers and hospital networks have facilitated robust post-market surveillance, yielding real-world evidence that bolsters clinical confidence. Reimbursement frameworks have also adapted, with payers recognizing the long-term cost savings of minimally invasive procedures over open surgical interventions. These combined forces have accelerated adoption, encouraging new entrants to invest in specialized delivery systems and digital platforms that support intraoperative decision-making. As these transformative shifts converge, they continue to shape the trajectory of device development and clinical practice.

Navigating the Impact of 2025 United States Tariffs

The implementation of new tariffs in the United States beginning in 2025 has introduced a complex layer of cost considerations for manufacturers, distributors, and healthcare providers. Imported raw materials and critical components used in device manufacturing now face elevated duties, prompting companies to reevaluate sourcing strategies and supply chain footprints. In response, some firms have accelerated efforts to localize production or establish regional manufacturing hubs, seeking to mitigate tariff-related expenses and maintain price stability for end users.

These adjustments have had cascading effects: procurement teams at hospitals and ambulatory centers have become more selective in device choice, balancing clinical efficacy against incremental cost pressures. In certain cases, collaborative agreements between device makers and group purchasing organizations have emerged to offset tariff impacts through volume discounts and value-based contracting. Despite these headwinds, a core segment of the market-particularly high-complexity aneurysm cases-remains relatively inelastic, as clinicians continue to prioritize proven therapeutic outcomes over marginal price differentials. Nonetheless, ongoing tariff volatility underscores the need for agile supply chain management and strategic pricing models.

Deep Dive into Market Segmentation Dynamics

The market’s segmentation by product type reveals a landscape defined by both specialization and convergence. Coils have long dominated procedural volumes, with subsegments spanning bare platinum designs, bioactive formulations that encourage endothelialization, and hydrogel coated variants available in multi layer or single layer configurations. At the same time, flow diverters are gaining traction as a preferred option for wide-neck aneurysms, while liquid embolics such as NBCA and Onyx offer complementary approaches for complex vascular geometries.

Beyond product type, procedural dynamics play a pivotal role: elective interventions account for the majority of cases, enabling thorough preoperative planning and device customization, whereas emergency procedures demand rapid device availability and streamlined workflows. End users further diversify the market, with hospitals handling high acuity and complex cases, ambulatory surgical centers offering efficiency for lower-risk interventions, and specialty clinics focusing on niche applications and follow-up care. Finally, the channel through which devices reach clinicians-whether through direct sales relationships that foster clinical education and support or through distributors that provide broader geographic coverage-influences service models and customer engagement strategies. By integrating these segmentation dimensions, stakeholders can tailor their product portfolios and go-to-market approaches to capture growth opportunities in each segment.

Regional Drivers Steering Market Growth

Across the Americas, demand for aneurysm coiling and embolization devices remains robust, driven by a well-established healthcare infrastructure and high procedural volumes. Key markets in North America benefit from favorable reimbursement policies and extensive clinical trial activity, while Latin American countries are increasingly adopting minimally invasive therapies in response to rising neurovascular disease prevalence.

In Europe, Middle East & Africa, heterogeneous regulatory environments shape device adoption rates. Western Europe continues to lead in uptake, supported by comprehensive post-market registries and center-of-excellence networks. The Middle East is emerging as a high-growth region, with government-led healthcare expansion and investment in advanced neurosurgical capabilities. Africa presents unique challenges but also untapped potential, as philanthropic initiatives and public-private partnerships begin to address infrastructure gaps.

The Asia-Pacific region exhibits dynamic growth trajectories justified by large patient populations and expanding neurology service lines. Countries such as Japan and Australia have well-defined reimbursement schemes that support innovation, while rapidly developing markets in Southeast Asia and India are witnessing increased capital investment in high-end medical technologies. These regional nuances underscore the importance of localized strategies, from regulatory engagement to targeted clinical education programs.

Competitive Landscape and Leading Innovators

The competitive landscape is anchored by a mix of legacy players and agile newcomers, each driving innovation through targeted product development and strategic alliances. Established medical device corporations continue to refine coil materials and delivery systems, leveraging decades of clinical data to optimize safety profiles and procedural efficiency. Simultaneously, specialist firms are disrupting the status quo with novel flow diverter architectures, smart polymers that enhance aneurysm sealing, and digital platforms that integrate imaging analytics with device deployment.

Collaborative initiatives between manufacturers and academic research centers are yielding a steady pipeline of next-generation solutions, from bioresorbable scaffolds to microcatheter enhancements that improve navigability in tortuous vasculature. Mergers and acquisitions have also reshaped the market, with larger entities absorbing high-growth startups to diversify portfolios and accelerate entry into adjacent interventional segments. As these dynamics evolve, companies that combine broad geographic reach with nimble R&D capabilities are best positioned to capture emerging opportunities and address evolving clinician requirements.

Strategic Imperatives for Market Leadership

Industry leaders should prioritize the integration of advanced materials science with digital support tools, ensuring that future device iterations deliver both enhanced therapeutic efficacy and streamlined clinical workflows. Strengthening partnerships with key opinion leaders and neurosurgical centers will be essential to generate real-world evidence and drive guideline adoption. Companies must also explore collaborative procurement models with healthcare systems to share risk, demonstrate cost-effectiveness, and secure preferred vendor status.

Moreover, expanding educational initiatives through virtual reality simulations and remote proctoring can accelerate clinician proficiency, particularly in emerging markets and lower-volume centers. Portfolio diversification-spanning coils, flow diverters, and liquid embolics-will help firms capture a broader share of treatment protocols while hedging against shifts in clinical preference. Finally, investing in localized manufacturing and supply chain resilience will mitigate geopolitical and tariff-driven disruptions, enabling more predictable delivery timelines and competitive pricing for end users.

Rigorous Research Approach and Methodology

This research combines primary insights with secondary data to present a holistic view of the aneurysm coiling and embolization market. Primary research was conducted through in-depth interviews with neurointerventional specialists, procurement managers, and industry executives across key regions. These conversations provided firsthand perspectives on clinical trends, procedural preferences, and purchasing criteria.

Secondary sources included peer-reviewed journals, regulatory filings, patent databases, and industry conference presentations. Each data point was triangulated to ensure validity, with discrepancies reconciled through follow-up inquiries or supplementary literature reviews. The analysis also incorporated regional regulatory frameworks and reimbursement policies to contextualize market drivers.

Quantitative techniques, such as market share analysis and trend extrapolation, were complemented by qualitative assessments of competitive dynamics and innovation pipelines. Rigorous quality control measures, including peer review by senior analysts and verification against third-party databases, guarantee the robustness and reliability of the findings.

Concluding Perspectives on Market Trajectory

In conclusion, the aneurysm coiling and embolization devices market stands at a pivotal juncture defined by rapid technological advancement, shifting economic pressures, and dynamic competitive forces. The convergence of novel materials, digital enhancements, and streamlined regulatory pathways is fostering a new era of therapeutic options that promise improved patient outcomes and operational efficiencies.

However, external factors such as tariff adjustments and regional healthcare disparities inject a layer of complexity that requires nimble strategic planning. Companies that embrace holistic segmentation strategies-spanning product innovation, procedure specialization, and targeted market engagement-will be best positioned to capture emerging growth pockets. By adhering to rigorous evidence-generation practices and forging collaborative partnerships, stakeholders can navigate uncertainties and drive sustainable value creation.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Coils
      • Bare Platinum
      • Bioactive
      • Hydrogel Coated
        • Multi Layer
        • Single Layer
    • Flow Diverters
    • Liquid Embolics
      • NBCA
      • Onyx
  • Procedure Type
    • Elective
    • Emergency
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
  • Sales Channel
    • Direct Sales
    • Distributors
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Johnson & Johnson
  • Medtronic plc
  • Stryker Corporation
  • Penumbra, Inc.
  • Boston Scientific Corporation
  • Terumo Corporation
  • Kaneka Corporation
  • MicroPort Scientific Corporation
  • Balt Extrusion S.A.
  • MicroVention, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Aneurysm Coiling & Embolization Devices Market, by Product Type
8.1. Introduction
8.2. Coils
8.2.1. Bare Platinum
8.2.2. Bioactive
8.2.3. Hydrogel Coated
8.2.3.1. Multi Layer
8.2.3.2. Single Layer
8.3. Flow Diverters
8.4. Liquid Embolics
8.4.1. NBCA
8.4.2. Onyx
9. Aneurysm Coiling & Embolization Devices Market, by Procedure Type
9.1. Introduction
9.2. Elective
9.3. Emergency
10. Aneurysm Coiling & Embolization Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Aneurysm Coiling & Embolization Devices Market, by Sales Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
12. Americas Aneurysm Coiling & Embolization Devices Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Aneurysm Coiling & Embolization Devices Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Aneurysm Coiling & Embolization Devices Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Johnson & Johnson
15.3.2. Medtronic plc
15.3.3. Stryker Corporation
15.3.4. Penumbra, Inc.
15.3.5. Boston Scientific Corporation
15.3.6. Terumo Corporation
15.3.7. Kaneka Corporation
15.3.8. MicroPort Scientific Corporation
15.3.9. Balt Extrusion S.A.
15.3.10. MicroVention, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ANEURYSM COILING & EMBOLIZATION DEVICES MARKET MULTI-CURRENCY
FIGURE 2. ANEURYSM COILING & EMBOLIZATION DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. ANEURYSM COILING & EMBOLIZATION DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANEURYSM COILING & EMBOLIZATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY BARE PLATINUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY BIOACTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY MULTI LAYER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SINGLE LAYER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY NBCA, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY ONYX, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY ELECTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY EMERGENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. CANADA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 48. CANADA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 49. CANADA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 50. CANADA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 51. CANADA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. CANADA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. MEXICO ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. MEXICO ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 55. MEXICO ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 56. MEXICO ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 57. MEXICO ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 58. MEXICO ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. MEXICO ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. UNITED KINGDOM ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED KINGDOM ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 84. UNITED KINGDOM ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. GERMANY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. GERMANY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 91. GERMANY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 92. GERMANY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 93. GERMANY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. GERMANY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. FRANCE ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. FRANCE ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 98. FRANCE ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 99. FRANCE ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 100. FRANCE ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 101. FRANCE ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. FRANCE ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. RUSSIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. RUSSIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 105. RUSSIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 106. RUSSIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. ITALY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. ITALY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 112. ITALY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 113. ITALY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 114. ITALY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 115. ITALY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. ITALY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. SPAIN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. SPAIN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 119. SPAIN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 120. SPAIN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 121. SPAIN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 122. SPAIN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. SPAIN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. UNITED ARAB EMIRATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. UNITED ARAB EMIRATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 126. UNITED ARAB EMIRATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 127. UNITED ARAB EMIRATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. SAUDI ARABIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. SAUDI ARABIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 133. SAUDI ARABIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 134. SAUDI ARABIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 135. SAUDI ARABIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. SOUTH AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. SOUTH AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 140. SOUTH AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 141. SOUTH AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 142. SOUTH AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. DENMARK ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. DENMARK ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 147. DENMARK ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 148. DENMARK ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 149. DENMARK ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 150. DENMARK ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. DENMARK ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. NETHERLANDS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. NETHERLANDS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 154. NETHERLANDS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 155. NETHERLANDS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. QATAR ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. QATAR ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 161. QATAR ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 162. QATAR ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 163. QATAR ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 164. QATAR ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. QATAR ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. FINLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. FINLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 168. FINLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 169. FINLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 170. FINLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 171. FINLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. FINLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. NIGERIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. NIGERIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 182. NIGERIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 183. NIGERIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. EGYPT ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. EGYPT ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 189. EGYPT ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 190. EGYPT ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 191. EGYPT ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 192. EGYPT ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. EGYPT ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. TURKEY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. TURKEY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 196. TURKEY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 197. TURKEY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 198. TURKEY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 199. TURKEY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. TURKEY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. ISRAEL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. ISRAEL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 203. ISRAEL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 204. ISRAEL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 205. ISRAEL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. NORWAY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. NORWAY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 210. NORWAY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 211. NORWAY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 212. NORWAY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 213. NORWAY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. NORWAY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. POLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. POLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 217. POLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 218. POLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 219. POLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 220. POLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. POLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 237. CHINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. CHINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 239. CHINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 240. CHINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 241. CHINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 242. CHINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. CHINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. INDIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. INDIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 246. INDIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 247. INDIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 248. INDIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 249. INDIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. INDIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. JAPAN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 252. JAPAN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 253. JAPAN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 254. JAPAN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 255. JAPAN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 256. JAPAN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. JAPAN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. AUSTRALIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. AUSTRALIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. SOUTH KOREA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. SOUTH KOREA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. INDONESIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. THAILAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. THAILAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 281. THAILAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HYDROGEL COATED, 2018-2030 (USD MILLION)
TABLE 282. THAILAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLICS, 2018-2030 (USD MILLION)
TABLE 283. THAILAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 284. THAILAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. THAILAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. PHILIPPINES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. PHILIPPINES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COILS, 2018-2030 (USD MILLION)
TABLE 288. PHILIPPINES ANEURYSM COILING & EMBOLIZATION DEVICE

Companies Mentioned

The companies profiled in this Aneurysm Coiling & Embolization Devices market report include:
  • Johnson & Johnson
  • Medtronic plc
  • Stryker Corporation
  • Penumbra, Inc.
  • Boston Scientific Corporation
  • Terumo Corporation
  • Kaneka Corporation
  • MicroPort Scientific Corporation
  • Balt Extrusion S.A.
  • MicroVention, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 356.4 Million
Forecasted Market Value ( USD ) by 2030 $ 585.26 Million
Compound Annual Growth Rate10.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Aneurysm Coiling and Embolization Devices Market 2025-2029 - Product Image

Aneurysm Coiling and Embolization Devices Market 2025-2029

  • Report
  • 184 Pages
  • Global
From
Vascular Embolization Devices - Global Strategic Business Report - Product Image

Vascular Embolization Devices - Global Strategic Business Report

  • Report
  • 250 Pages
  • Global
From
Neurovascular Embolization Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Neurovascular Embolization Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Neurovascular Embolization Devices - Global Strategic Business Report - Product Image

Neurovascular Embolization Devices - Global Strategic Business Report

  • Report
  • 284 Pages
  • Global
From
Neurovascular Embolization Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Neurovascular Embolization Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 128 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.